As Illumina stock bounces off a 10-year low, analysts see no quick fix

DNA-sequencing company juggles leadership transition, questions about a new product launch, and unwinding of a troubled acquisition
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.